| Dr Anthony C Faber, MD | |
|
630 Medical Dr, Bountiful, UT 84010-4908 | |
| (877) 594-2787 | |
| Not Available |
| Full Name | Dr Anthony C Faber |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 630 Medical Dr, Bountiful, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083626303 | NPI | - | NPPES |
| D0109 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 186930-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeview Hospital | Bountiful, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Anesthesia Associates Llc | 3274590856 | 12 |
News Archive
For the 14th straight year, Eli Lilly and Company honors mental health professionals and individuals for their exceptional contributions and achievements in helping those battling serious mental illness.
A wearable monitoring device to make treatments easier and more affordable for the millions of people with swallowing disorders is about to be released into the market.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and at Ghent University in Ghent, Belgium, have identified a new role for certain lung cells in the immune response to airborne allergens.
Mary Fanning, South Africa's country coordinator for PEPFAR, writes in a New Age guest column, "In the fight against HIV/AIDS, this is a time of hope. It's also a time to celebrate the partnerships that are advancing this work and to recommit to a plan to ensure prevention, treatment and care for those infected and affected is sustainable and locally managed."
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the U.S. Food and Drug Administration has accepted the Company's investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors specific for MAGE A10 (MAGE-A10 T) in patients with locally advanced or metastatic non-small cell lung cancer, and that the IND is now active.
› Verified 7 days ago
| Entity Name | Western Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174566277 PECOS PAC ID: 3274590856 Enrollment ID: O20041215000445 |
News Archive
For the 14th straight year, Eli Lilly and Company honors mental health professionals and individuals for their exceptional contributions and achievements in helping those battling serious mental illness.
A wearable monitoring device to make treatments easier and more affordable for the millions of people with swallowing disorders is about to be released into the market.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and at Ghent University in Ghent, Belgium, have identified a new role for certain lung cells in the immune response to airborne allergens.
Mary Fanning, South Africa's country coordinator for PEPFAR, writes in a New Age guest column, "In the fight against HIV/AIDS, this is a time of hope. It's also a time to celebrate the partnerships that are advancing this work and to recommit to a plan to ensure prevention, treatment and care for those infected and affected is sustainable and locally managed."
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the U.S. Food and Drug Administration has accepted the Company's investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors specific for MAGE A10 (MAGE-A10 T) in patients with locally advanced or metastatic non-small cell lung cancer, and that the IND is now active.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony C Faber, MD 630 Medical Dr, Bountiful, UT 84010-4908 Ph: (877) 594-2787 | Dr Anthony C Faber, MD 630 Medical Dr, Bountiful, UT 84010-4908 Ph: (877) 594-2787 |
News Archive
For the 14th straight year, Eli Lilly and Company honors mental health professionals and individuals for their exceptional contributions and achievements in helping those battling serious mental illness.
A wearable monitoring device to make treatments easier and more affordable for the millions of people with swallowing disorders is about to be released into the market.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and at Ghent University in Ghent, Belgium, have identified a new role for certain lung cells in the immune response to airborne allergens.
Mary Fanning, South Africa's country coordinator for PEPFAR, writes in a New Age guest column, "In the fight against HIV/AIDS, this is a time of hope. It's also a time to celebrate the partnerships that are advancing this work and to recommit to a plan to ensure prevention, treatment and care for those infected and affected is sustainable and locally managed."
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the U.S. Food and Drug Administration has accepted the Company's investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors specific for MAGE A10 (MAGE-A10 T) in patients with locally advanced or metastatic non-small cell lung cancer, and that the IND is now active.
› Verified 7 days ago
E. Wayne Larsen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 801-299-2160 Fax: 801-299-2549 | |
Dr. Keith Arthur Kirkham, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 877-594-2787 | |
Tory Scott Hinkle, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 877-594-2787 | |
Dr. Blake J Brown, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 877-594-2787 | |
Bryce Trump, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 877-594-2787 | |
G. Scott Oldroyd, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 973 Bountiful Hills Dr, Bountiful, UT 84010 Phone: 801-726-2211 |